Ackermann P, Brachert M, Albrecht P, Ringelstein M, Finis D, Aktas O, Geerling G, Guthoff R. Alterations of the Outer Retina in Non-arteritic Anterior Ischemic Optic Neuropathy Detected using Spectral-domain Optical Coherence Tomography. Clinical and Experimental Ophthalmology 2017; 45: 496-508.

Akkermann R, Beyer F, Küry P. Heterogeneous populations of neural stem cells contribute to myelin repair. Neural Regenration Research 2017; 12: 509-517.

Albrecht P, Blasberg C, Ringelstein M, Müller AK, Finis D, Guthoff R, Kadas EM, Lagreze W, Aktas O, Hartung HP, Paul F, Brandt AU, Methner A. Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension. Journal of Neurology 2017; 264: 1370-1380.

Angel HF, Seitz RJ. Violations of Expectations As Matter for the Believing Process. Frontiers in Psychology 2017; 8: 772.

Arnold DL, Calabresi PA, Kieseier BC, Liu S, You X, Gasparotto D, Hung S. Peginterferon beta-1a improves MRI measures and increases the proportion of patients with no evidence of disease activity in relapsing-remitting multiple sclerosis: 2-year results from the ADVANCE randomized controlled trial. BMC Neurology 2017; 17: 29.

Baumgarten TJ, Schnitzler A, Lange J. Beyond the Peak - Tactile Temporal Discrimination Does Not Correlate with Individual Peak Frequencies in Somatosensory Cortex. Frontiers in Psychology 2017; 8: 421.

Bekeschus S, Bräutigam L, Wende K, Hanschmann EM.. Oxidants and Redox Signaling: Perspectives in Cancer Therapy, Inflammation, and Plasma Medicine. Oxidative Medicine and Cellular Longevity 2017; 2017: 4020253.

Berndt C, Lillig CH. Glutathione, Glutaredoxins, and iron. Antioxidants & Redox Signaling 2017; 27: 1235-1251.

Borisow N, Kleiter I, Gahlen A, Fischer K, Wernecke KD, Pache F, Ruprecht K, Havla J, Krumbholz M, Kümpfel T, Aktas O, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Weissert R, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker RA, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Winkelmann A, Marouf W, Rückriem L, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C, Hellwig K; NEMOS (Neuromyelitis Optica Study Group). Influence of female sex and fertile age on neuromyelitis optica spectrum disorders. Multiple Sclerosis Journal 2017; 23: 1092-1103.

Brandt AU, Zimmermann H, Scheel M, Finke C, Albrecht P, Paul F. Untersuchungen des visuellen Systems in der Neurologie: aktuelle Forschung und klinische Relevanz. Aktuelle Neurologie 2017; 44: 27-45.

Brazda N, Estrada V, Voss C, Seide K, Trieu K, Müller HW. Experimental strategies to bridge large tissue gaps in the injured spinal cord after acute and chronic lesion. Journal of Visualized Experiments: JoVE 2017; e53331.

Cadavid D, Cohen JA, Freedman MS, Goldman MD, Hartung HP, Havrdova E, Jeffery D, Kapoor R, Miller A, Sellebjerg F, Kinch D, Lee S, Shang S, Mikol D. The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis. Multiple Sclerosis Journal 2017; 23: 94-105.

Cadavid D, Balcer L, Galetta S, Aktas O, Ziemssen T, Vanopdenbosch L, Frederiksen J, Skeen M, Jaffe GJ, Butzkueven H, Ziemssen F, Massacesi L, Chai Y, Xu L, Freeman S; RENEW Study Investigators. Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial. Lancet Neurology 2017; 16: 189-199.

Caspers J, Mathys C, Hoffstaedter F, Südmeyer M, Cieslik EC, Rubbert C, Hartmann CJ, Eickhoff CR, Reetz K, Grefkes C, Michely J, Turowski B, Schnitzler A, Eickhoff SBDifferential Functional Connectivity Alterations of Two Subdivisions within the Right dlPFC in Parkinson's Disease. Frontiers in Human Neuroscience 2017; 11: 288.

Coles AJ, Cohen JA, Fox EJ, Giovannoni G, Hartung HP, Havrdova E, Schippling S, Selmaj KW, Traboulsee A, Compston DAS, Margolin DH, Thangavelu K, Chirieac MC, Jody D, Xenopoulos P, Hogan RJ, Panzara MA, Arnold DL; CARE-MS II and CAMMS03409 Investigators. Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings. Neurology 2017; 89: 1117-1126.

Comi G, Hartung HP, Bakshi R, Williams IM, Wiendl H. Benefit-Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis. Drugs 2017; 77: 1755-1768.

Cwik JC, Sartory G, Nuyken M, Schürholt B, Seitz RJ. Posterior and prefrontal contributions to the development posttraumatic stress disorder symptom severity: an fMRI study of symptom provocation in acute stress disorder. European Archives of Psychiatry and Clinical Neuroscience 2017; 267: 495-505.

Davis MD, Ashtamker N, Steinerman JR, Knappertz V.Time course of glatiramer acetate efficacy in patients with RRMS in the GALA study. Neurology, Neuroimmunology & Neuroinflammation 2017; 4: e327.

Delcourt C, Sato S, Zhang S, Sandset EC, Zheng D, Chen X, Hackett ML, Arima H, Hata J, Heeley E, Al-Shahi Salman R, Robinson T, Davies L, Lavados PM, Lindley RI, Stapf C, Chalmers J, Anderson CS; INTERACT2 Investigators. Intracerebral hemorrhage location and outcome among INTERACT2 participants. Neurology 2017; 88: 1408-1414.

Egea J, Fabregat I, Frapart YM, Ghezzi P, Görlach A, Kietzmann T, Kubaichuk K, Knaus UG. Lopez MG, Olaso-Gonzalez G, Petry A. Schulz R, Vina J, Winyard P, Abbas K, Ademowo S, Afonso CB, Andreadou I, (Berndt C) et al.; Position paper by the EU-ROS consortium on RONS in health and disease. European Contribution to the study of ROS: A Summary of the Findings and Prospects for the Future from the COST Action BM1203 (EU-ROS). Redox Biology 2017; 13: 94-162.

Eggers C, Arendt G, Hahn K, Husstedt IW, Maschke M, Neuen-Jacob E, Obermann M, Rosenkranz T, Schielke E, Straube E; German Association of Neuro-AIDS und Neuro-Infectiology (DGNANI). HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment. Journal of Neurology 2017; 264: 1715-1727.

Ehler J, Blechinger S, Rommer P, Koball S, Mitzner S, Hartung HP, Leutmezer F, Sauer M, Zettl U. Treatment of the first acute relapse following therapeutic plasma exchange in formerly glucocorticosteroid-unresponsive multiple sclerosis patients - a multicenter study to evaluate glucocorticosteroid-responsiveness. International Journal of Molecular Sciences 2017; 18: 1749.

Epstein KA, Viscoli CM, Spence JD, Young LH, Inzucchi SE, Gorman M, Gerstenhaber B, Guarino PD, Dixit A, Furie KL, Kernan WN; IRIS Trial Investigators. Smoking cessation and outcome after ischemic stroke or TIA. Neurology 2017; 89: 1723-1729.

Fernández O, Delvecchio M, Edan G, Fredrikson S, Gionvannoni G, Hartung HP, Havrdova E, Kappos L, Pozzilli C, Soerensen PS, Tackenberg B, Vermersch P, Comi G. Survey of diagnostic and treatment practices for multiple sclerosis in Europe. European Journal of Neurology 2017; 24: 516-522.

Fischer D. Hyper-IL-6: a potent and efficacious stimulator of RGC regeneration. Eye (Lond.) 2017; 31: 173-178.

Fischer D, Harvey A, Pernet V, Lemmons V, Park KK. Optic Nerve Regeneration in Mammals: Distinguishing Regenerating Versus Spared Axons. Experimental Neurology 2017; 296: 83-88.

Fitzgerald KC, Munger KL, Hartung HP, Freedman MS, Montalbán X, Edan G, Wicklein EM, Radue EW, Kappos L, Pohl C, Ascherio A. Sodium intake and multiple sclerosis activity and progression in BENEFIT. Annals of Neurology 2017; 82: 20-29.

Fleischer W, Theiss S, Schnitzler A, Sergeeva O. Glutamine triggers long-lasting increase in striatal network activity in vitro. Experimental Neurology 2017; 290: 41-52.

Freedman MS, Leist TP, Comi G, Cree BA, Coyle PK, Hartung HP, Vermersch P, Damian D, Dangond F. The efficacy of cladribine tablets in CIS patients retrospectively assigned the diagnosis of MS using modern criteria: results from the ORACLE-MS study. Multiple Sclerosis and Related Disorders 2017; 3: 2055217317732802.

Gahlen A, Trampe AK, Haupeltshofer S, Ringelstein M, Aktas O, Berthele A, Wildemann B, Gold R, Jarius S, Kleiter I. Aquaporin-4-antibodies in patients treated with natalizumab for suspected MS. Neurology, Neuroimmunology & Neuroinflammation 2017; 4: e363.

Geisler T, Poli S, Meisner C, Schreieck J, Zuern CS, Nägele T, Brachmann J, Jung W, Gahn G, Schmid E, Bäezner H, Keller T, Petzold GC, Schrickel JW, Liman J, Wachter R, Schön F, Schabet M, Lindner A, Ludolph AC, Kimmig H, Jander S, Schlegel U, Gawaz M, Ziemann U. Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): Rationale and study design. International Journal of Stroke 2017; 12: 985-990.

Gliem M, Lee JI, Barckhan A, Turowski B, Hartung HP, Jander S. Outcome and Treatment Effects in Stroke Associated with Acute Cervical ICA Occlusion. PLoS One 2017; 12: e0170247.

Gowert NS, Krüger I, Klier M, Donner L, Kipkeew F, Gliem M, Bradshaw NJ, Lutz D, Köber S, Langer H, Jander S, Jurk K, Frotscher M, Korth C, Bock HH, Elvers M. Loss of Reelin protects mice against arterial thrombosis by impairing integrin activation and thrombus formation under high shear conditions. Cellular Signalling 2017; 40: 210-221.

Graf J, Leussink VI, Dehmel T, Ringelstein M, Goebels N, Adams O, MacKenzie CR, Warnke C, Feldt T, Lammerskitten A, Klotz L, Meuth S, Wiendl H, Hartung HP, Aktas O, Albrecht P. Infectious risk stratification in multiple sclerosis patients receiving immunotherapy. Annals Clinical Translational Neurology 2017; 4: 909-914.

Graf J, Ringelstein M, Aktas O, Wattjes MP, Hartung HP. Fulminant intramedullary spinal cord sarcoidosis. Multiple Sclerosis & Related Disorders 2017; 18: 47-48.

Gratkowski M, Storzer L, Butz M, Schnitzler A, Saupe D, Dalal SSBrainCycles: Experimental Setup for the Combined Measurement of Cortical and Subcortical Activity in Parkinson's Disease Patients during Cycling. Frontiers in Human Neuroscience 2017; 10: 685.

Groiss SJ, Trenado C, Sabel M, Schnitzler A, Wojtecki L. Focal seizure induced by preoperative navigated transcranial magnetic stimulation in a patient with anaplastic oligoastrocytoma. Brain Stimulation 2017; 10: 331-332.

Groiss SJ, Mochizuki H, Hanajima R, Trenado C, Nakatani-Enomoto S, Otani K, Ugawa Y.Impairment of triad conditioned facilitation in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degenration 2017; 18: 604-610.

Hartlehnert M, Derksen A, Hagenacker T, Kindermann D, Schäfers M, Pawlak M, Kieseier BC, Meyer Zu Horste G. Schwann cells promote post-traumatic nerve inflammation and neuropathic pain through MHC class II. Scientific Reports 2017; 7: 12518.

Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis. New England Journal of Medicine 2017; 376: 221-234.

Havrdova E, Arnold DL, Cohen JA, Hartung HP, Fox EJ, Giovannoni G, Schippling S, Selmaj KW, Traboulsee A, Compston DAS, Margolin DH, Thangavelu K, Rodriguez CE, Jody D, Hogan RJ, Xenopoulos P, Panzara MA, Coles AJ; CARE-MS I and CAMMS03409 Investigators. Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy. Neurology 2017; 89: 1107-1116.

Hefter H, Rosenthal D. Improvement of upper trunk posture during walking in hemiplegic patients after injections of botulinum toxin into the arm. Clinical Biomechanics 2017; 43: 15-22.

Hilla AM, Diekmann H, Fischer D. Microglia are irrelevant for neuronal degeneration and axon regeneration after acute injury. Journal of Neuroscience 2017; 37: 6113-6124.

Hoffmann C, Dietrich M, Herrmann AK, Schacht T, Albrecht P, Methner A. Dimethyl Fumarate Induces Glutathione Recycling by Upregulation of Glutathione Reductase. Oxidative Medicine & Cellular Longevity 2017; 2017: 6093903.

Horn A, Scheller C, du Plessis S, Burger R, Arendt G, Joska J, Sopper S, Maschke CM, Obermann M, Husstedt IW, Hain J, Riederer P, Koutsilieri E; German Competence Network HIV/AIDS. The dopamine-related polymorphisms BDNF, COMT, DRD2, DRD3, and DRD4 are not linked with changes in CSF dopamine levels and frequency of HIV infection. Journal of Neural Transmission 2017; 124: 501-509.

Hummel S, Rosenthal D, Zilkens C, Hefter H, Krauspe R, Westhoff B. Gait deviations in transverse plane after SCFE in dependence on the femoral offset. Gait & Posture 2017; 58: 358-362.

Ingenhoven K, Kramer D, Jensen PE, Hermanrud C, Ryner M, Deisenhammer F, Pallardy M, Menge T, Hartung HP, Kieseier BC, Bertotti E, Creeke P, Fogdell-Hahn A, Warnke C; on behalf of the ABIRISK Consortium. Development and validation of enzyme-linked immunosorbent assay for the detection of binding anti-drug antibodies against interferon beta. Frontiers in Neurology 2017; 8: 305.

Jacobs BC, van den Berg B, Verboon C, Chavada G, Cornblath DR, Gorson KC, Harbo T, Hartung HP, Hughes RAC, Kusunoki S, van Doorn PA, Willison HJ; IGOS Consortium. International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome. Journal of the Peripheral Nervous System 2017; 22: 68-76.

Kermer P, Eschenfelder CC, Diener HC, Grond M, Abdalla Y, Althaus K, Berrouschot J, Cangür H, Daffertshofer M, Edelbusch S, Gröschel K, Haase CG, Harloff A, Held V, Kauert A, Kraft P, Lenz A, Müllges W, Obermann M, Partowi S, Purrucker J, Ringleb PA, Röther J, Rossi R, Schäfer N, Schneider A, Schuppner R, Seitz RJ, Szabo K, Wruck R. Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany - A national case collection. International Journal of Stroke 2017; 12: 383-391.

Kleiser R, Stadler C, Wimmer S, Matyas T, Seitz RJ. An fMRI study of training voluntary smooth circular eye movements. Experimental Brain Research 2017; 235: 819-831.

Klepp A, Niccolai V, Sieksmeyer J, Arnzen S, Indefrey P, Schnitzler A, Biermann-Ruben K. Body-part specific interactions of action verb processing with motor behaviour. Behavioural Brain Research 2017; 328: 149-158.

Kloeters S, Hartmann CJ, Pundmann VD, Schnitzler A, Südmeyer M, Lange J. Impaired perception of human movements in Parkinson's disease. Behavioural Brain Resarch 2017; 317: 88-94.

Koch MW, Cutter GR, Giovannoni G, Uitdehaag BM, Wolinsky JS, Steinerman JR, Knappertz V. Comparative utility of disability progression measures in PPMS. Neurology: Neuroimmunology & Neuroinflammation 2017; 4: e358.

Köhler W, Fischer M, Bublak P., Faiss JH, Hoffmann F, Kunkel A, Sailer M, Schwab M, Stadler E, Zettl U, Penner IK. Information processing deficits as a driving force for memory impairment in MS: A cross--sectional study of memory functions and MRI in early and late stage MS. Multiple Sclerosis and Related Disorders 2017; 18, 119-127.

Koy A, Weinsheimer M, Pauls KA, Kühn AA, Krause P, Huebl J, Schneider GH, Deuschl G, Erasmi R, Falk D, Krauss JK, Lütjens G, Schnitzler A, Wojtecki L, Vesper J, Korinthenberg R, Coenen VA, Visser-Vandewalle V, Hellmich M, Timmermann L; GEPESTIM Consortium. German registry of paediatric deep brain stimulation in patients with childhood-onset dystonia (GEPESTIM). European Journal of Paediatric Neurology 2017; 21: 136-146.

Kraemer M, Trakolis L, Platzen J, Schwitalla JC, Bersano A, Albrecht P, Schlamann M, Berlit P. Movement symptoms in European Moyamoya angiopathy - First systematic questionnaire study. Clinical Neurology & Neurosurgery 2017; 152: 52-56.

Kremer D, Glanzman R, Traboulsee A, Nath A, Groc L, Horwitz M, Göttle P, Perron H, Gold J, Hartung HP, Küry P. Prehistoric enemies within: The contribution of human endogenous retroviruses to neurological diseases. Meeting report: "Second International Workshop on Human Endogenous Retroviruses and Disease", Washington DC, March 13th and 14th 2017. Multiple Sclerosis & Related Disorders 2017; 15: 18-23.

Kunstreich M, Kreth JH, Oommen PT, Schaper J, Karenfort M, Aktas O, Tibussek D, Distelmaier F, Borkhardt A, Kuhlen M. Paraneoplastic limbic encephalitis with SOX1 and PCA2 antibodies and relapsing neurological symptoms in an adolescent with Hodgkin lymphoma. European Journal of Paediatric Neurology 2017; 21: 661-665.

Lee JI, Jander S. Myasthenia gravis: recent advances in immunopathology and therapy. Expert Review of Neurotherapeutics 2017; 17: 287-299.

Lee JI, Gliem M, Gerdes G, Turowski B, Kaschner M, Kraus B, Hartung HP, Jander S. Safety of bridging antiplatelet therapy with the gpIIb-IIIa inhibitor tirofiban after emergency stenting in stroke. PLoS One 2017; 12: e0190218

Leibinger M, Andreadaki A, Golla R, Levin E, Hilla AM, Diekmann H, Fischer D. Boosting CNS axon regeneration by harnessing antagonistic effects of GSK3 activity Proceedings of the National Academy of Sciences 2017; 114: e5454-e5463.

Lepka K, Volbracht K, Bill E, Schneider R, Rios N, Hildebrandt T, Ingwersen J, Prozorovski T, Lillig CH, van Horssen J, Steinman L, Hartung HP, Radi R, Holmgren A, Aktas O, Berndt C. Iron-sulfur glutaredoxin 2 protects oligodendrocytes against damage induced by nitric oxide release from activated microglia. Glia 2017; 65: 1521-1534.

Levin E, Andreadaki A, Gobrecht P, Bosse F, Fischer D. Nociceptive DRG neurons express muscle lim protein upon axonal injury. Scientific Reports 2017; 7: 643.

Link J, Ramanujam R, Auer M, Ryner M, Hässler S, Bachelet D, Mbogning C, Warnke C, Buck D, Hyldgaard Jensen PE, Sievers C, Ingenhoven K, Fissolo N, Lindberg R, Grummel V, Donnellan N, Comabella M, Montalban X, Kieseier B, Soelberg Sørensen P, Hartung HP, Derfuss T, Lawton A, Sikkema D, Pallardy M, Hemmer B, Deisenhammer F, Broët P, Dönnes P, Davidson J, Fogdell-Hahn A; ABIRISK Consortium. Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results. PLoS One 2017; 12: e0170395.

Lorenzen I, Mullen L, Bekeschus S, Hanschmann EM. Redox Regulation of Inflammatory Processes Is Enzymatically Controlled, Oxidative Medicine and Cellular Longevity 2017; 2017: 8459402.

Maier F, Lewis CJ, Eggers C, Kühn AA, Krug H, Volkmann J, Kirsch AD, Wojtecki L, Schnitzler A, Deuschl G, Krauss JK, Woopen C, Timmermann The deep brain stimulation impairment scale (DBS-IS). Parkinsonism & Related Disorders 2017; 36: 69-75.

Maier F, Lewis CJ, Eggers C, Kühn AA, Krug H, Volkmann J, Kirsch AD, Wojtecki L, Schnitzler A, Deuschl G, Krauss JK, Woopen C, Timmermann L. The deep brain stimulation impairment scale (DBS-IS). Parkinsonism & Related Disorders 2017; 41: 133-134.

Makimoto H, Kurt M, Gliem M, Lee JI, Schmidt J, Müller P, Gerguri S, Clasen L, Brinkmeyer C, Dimitroulis D, Jander S, Kelm M, Fürnkranz A. High Incidence of Atrial Fibrillation after Embolic Stroke of Undetermined Source in Posterior Cerebral Artery Territory. Journal of the American Heart Association 2017; 6: e007448.

Malviya M, Barman S, Golombeck KS, Planaguma J, Mannara F, Strutz-Seebohm N, Wroz C, Demir F, Baksmeier C, Steckel J, Falk KK, Gross CC, Kovac S, Bönte K, Johnen A, Wandinger KP, Martin-Garcia E, Becker AJ, Elger CE, Klöcker N, Wiendl H, Meuth SG, Hartung HP, Seebohm G, Leypoldt F, Maldonado R, Stadelmann C, Dalmau J, Melzer N, Goebels N. NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody. Annals of Clinical and Translational Neurology 2017; 4: 768-783.

Merckx E, Albertini G, Paterka M, Jensen C, Albrecht P, Dietrich M, van Liefferinge J, Bentea E, Verbruggen L, Demuyser T, Deneyer L, Lewerenz J, van Loo G, de Keyser J, Sato H, Maher P, Methner A, Massie A. Absence of system xc- on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis. Journal of Neuroinflammation 2017; 14: 9.

Möller L, Kassubek J, Südmeyer M, Hilker R, Hattingen E, Egger K, Amtage F, Pinkhardt EH, Respondek G, Stamelou M, Möller F, Schnitzler A, Oertel WH, Knake S, Huppertz HJ, Höglinger GU. Manual MRI morphometry in Parkinsonian syndromes. Movement Disorders 2017; 32: 778-782.

Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, Mairon N, Chin P, Wolinsky JS; ORATORIO Clinical Investigators. Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis. New England Journal of Medicine 2017; 376: 209-220.

Müller PL, Fimmers R, Gliem M, Holz FG, Charbel Issa P. Choroidal alterations in abca4-related retinopathy. Retina 2017; 37: 359-367.

Newsome SD, Kieseier BC, Liu S, You X, Kinter E, Hung S, Sperling B. Peginterferon beta-1a reduces disability worsening in relapsing-remitting multiple sclerosis: 2-year results from ADVANCE. Therapeutic Advances in Neurological Disorders 2017; 10: 41-50.

Oervik MS, Sejbaek T, Penner IK, Roar M, Blaabjerg M. Validation of the fatigue scale for motor and cognitive functions in a danish multiple sclerosis cohort. Multiple Sclerosis and Related Disorders 2017; 17, 130-134.

Penner IK, Aktas O. Functional reorganization is a maladaptive response to injury – NO. Multiple Sclerosis Journal 2017; 23: 193-194.

Penner IK, Paul F. Fatigue as a symptom or comorbidity of neurological diseases. Nature Reviews Neurology 2017; 13: 662-675.

Penner IK. Cognition in multiple sclerosis. Neurodegenerative Disease Management 2017; 7, 19-21.

Petzold A, Balcer LJ, Calabresi PA, Costello F, Frohman TC, Frohman EM, Martinez-Lapiscina EH, Green AJ, Kardon R, Outteryck O, Paul F, Schippling S, Vermersch P, Villoslada P, Balk LJ; ERN-EYE IMSVISUAL [Albrecht P, Aktas O]. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurology 2017; 16: 797-812.

Pilz G, Wipfler P, Schwarte O, Golaszewski S, McCoy M, Haschke-Becher E, Hartung HP, Kraus J. Coronary angiography as a rare cause for incomplete anterior spinal artery syndrome. Journal of Neurology 2017; 264: 799-801.

Pingel S, Pausewang KS, Passon SG, Blatzheim AK, Gliem M, Charbel Issa P, Hendig D, Horlbeck F, Tuleta I, Nickenig G, Schahab N, Skowasch D, Schaefer CA. Increased vascular occlusion in patients with pseudoxanthoma elasticum. Vasa 2017; 46: 47-52.

Plavina T, Muralidharan K, Kuesters G, Mikol D, Evans K, Subramanyam M, Nestorov I, Chen Y, Dong Q, Ho PR, Amarante D, Adams A, de Sèze, J,  Fox R, Gold R, Jeffery D, Kappos L, Montalban X, Weinstock-Guttmann B, Hartung HP, Cree B. Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients. Neurology 2017; 89: 1584-1593.

Purrucker JC, Haas K, Wolf M, Rizos T, Khan S, Kraft P, Poli S, Dziewas R, Meyne J, Palm F, Jander S, Möhlenbruch M, Heuschmann PU, Veltkamp R; the.RASUNOA investigators. Haemorrhagic Transformation after Ischaemic Stroke in Patients Taking Non-vitamin K Antagonist Oral Anticoagulants. Journal of Stroke 2017; 19: 67-76.

Purrucker JC, Haas K, Rizos T, Khan S, Poli S, Kraft P, Kleinschnitz C, Dziewas R, Binder A, Palm F, Jander S, Soda H, Heuschmann PU, Veltkamp R; RASUNOA Investigators (Registry of Acute Stroke Under New Oral Anticoagulants). Coagulation Testing in Acute Ischemic Stroke Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants. Stroke 2017; 48: 152-158.

Rajabally YA, Stettner M, Kieseier BC, Hartung HP, Malik RA. Inflammatory Neuropathies and Diabetes: Epidemiological uncertainties, diagnostic difficulties and implications for management. Nature Reviews Neurology 2017; 13: 599-611.

Romero JI, Holubiec MI, Tornatore TL, Rivière S, Hanschmann EM, Kölliker-Frers RA, Tau J. Blanco E, Galeano P, Rodríguez de Fonseca F, Lillig CH, Capani F. Neuronal Damage Induced by Perinatal Asphyxia is Attenuated by Postinjury Glutaredoxin-2 Administration. Oxidative Medicine and Cellular Longevity 2017; 2017: 4162465.

Sasidhar MV, Chevooru SK, Eickelberg O, Hartung HP, Neuhaus O. Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. PLoS One 2017; 12: e018970.

Scolding NJ, Pasquini M, Reingold SC, Cohen JA; International Conference on Cell-Based Therapies for Multiple Sclerosis; International Conference on Cell-Based Therapies for Multiple Sclerosis; International Conference on Cell-Based Therapies for Multiple Sclerosis. Cell-based therapeutic strategies for multiple sclerosis. Brain 2017; 140: 2776-2796.

Scott TF, Kieseier BC, Newsome SD, Arnold DL, You X, Hung S, Sperling B. Improvement in relpase recovery with peginterferon beta-1a in patients with multiple sclerosis. Multiple Sclerosis Journal 2017; 2: 1-8.

Seitz RJ, Paloutzian RF and Angel HF. Processes of believing: Where do they come from? What are they good for? F1000Research 2017, 5: 2573.

Sies H, Berndt C, Jones DP. Oxidative Stress. Annual Review of Biochemistry 2017; 86: 715-748.

Skowron MA, Niegisch G, Albrecht P, van Koeveringe G, Romano A, Albers P, Schulz WA, Hoffmann MJ. Various Mechanisms Involve the Nuclear Factor (Erythroid-Derived 2)-Like (NRF2) to Achieve Cytoprotection in Long-Term Cisplatin-Treated Urothelial Carcinoma Cell Lines.International Journal of Molecular Sciences 2017; 18: 1680.

Stellmann JP, Krumbholz M, Friede T, Gahlen A, Borisow N, Fischer K, Hellwig K, Pache F, Ruprecht K, Havla J, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Young KL, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker RA, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Zettl U, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C, Kleiter I; NEMOS (Neuromyelitis Optica Study Group). Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response. Journal of Neurology, Neurosurgery & Psychiatry 2017; 88: 639-647.

Szepanowski F, Donaldson DM, Hartung HP, Kieseier BC, Stettner M. Dimethyl fumarate accelerates peripheral nerve regeneration via activation of the anti-inflammatory and cytoprotective Nrf2/HO-1 signaling pathway. Acta Neuropathologica 2017; 133: 489-491.

Trenado C, Elben S, Friggemann L, Gruhn S, Groiss SJ, Vesper J, Schnitzler A, Wojtecki L. Long-Latency Somatosensory Evoked Potentials of the Subthalamic Nucleus in Patients with Parkinson's Disease. PLoS One 2017; 12: e0168151.

Trenado C, Elben S, Friggemann L, Gruhn S, Groiss SJ, Vesper J, Schnitzler A, Wojtecki L. Correction: Long-Latency Somatosensory Evoked Potentials of the Subthalamic Nucleus in Patients with Parkinson's Disease. PLoS One 2017; 12: e0175602.

Uphaus T, Singer OC, Berkefeld J, Nolte CH, Bohner G, Niederkorn K, Deutschmann H, Haring HP, Trenkler J, Neumann-Haefelin T, Hofmann E, Stoll A, Bormann A, Bussmeyer M, Mpotsaris A, Reich A, Wiesmann M, Petzold GC, Urbach H, Jander S, Turowski B, Weimar C, Schlamann M, Liebeskind DS, Gröschel S, Boor S, Gröschel K. Safety of endovascular treatment in acute stroke patients taking oral anticoagulants. International Journal of Stroke 2017; 12: 412-415.

Ward ME, Chen R, Huang HY, Ludwig C, Telpoukhovskaia M, Taubes A, Boudin H, Minami SS, Reichert M, Albrecht P, Gelfand JM, Cruz-Herranz A, Cordano C, Alavi MV, Leslie S, Seeley WW, Miller BL, Bigio E, Mesulam MM, Bogyo MS, Mackenzie IR, Staropoli JF, Cotman SL, Huang EJ, Gan L, Green AJ. Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis. Science Translational Medicine 2017; 9: 385.

Warnke C, Wijburg MT, Hartung HP, Killestein J, Adams O, Wattjes MP. Application of the CSF JCV antibody index to early natalizumab-associated progressive multifocal leukoencephalopathy. Journal of Neurology, Neurosurgery & Psychiatry 2017; 88: 1092-1094.

Warnke C, Hartung HP. Natalizumab-associated progressive multifocal leukoencephalopathy is not preceded by elevated drug concentrations. Multiple Sclerosis Journal 2017; 23: 920-922.

Warnke C, Graf J, Hartung HP. Reconstitution of the peripheral immune repertoire following withdrawal of fingolimod: A commentary. Multiple Sclerosis 2017; 23: 1176-1178.

Wattjes MP, Warnke C. High-frequency MRI monitoring should be performed in natalizumab-treated MS patients with higher risk of PML - Commentary. Multiple Sclerosis Journal 2017; 23: 770-771.

Wojtecki L, Elben S, Vesper J, Schnitzler A. The rhythm of the executive gate of speech: subthalamic low-frequency oscillations increase during verbal generation.
European Journal of Neuroscience 2017; 45: 1200-1211.

Wojtecki L, Hirschmann J, Elben S, Boschheidgen M, Trenado C, Vesper J, Schnitzler A. Oscillatory Coupling of the Subthalamic Nucleus in Obsessive Compulsive Disorder Brain 2017, 140: e56.

Yamamura T, Ashtamker N, Ladkani D, Fukazawa T, Houzen H, Tanaka M, Miura T, Knappertz V. Once-daily glatiramer acetate decreases magnetic resonance imaging disease activity in Japanese patients with relapsing-remitting multiple sclerosis Clinical & Experimental Neuroimmunology 2017; 8: 129-137.

Ziemssen T, Ashtamker N, Rubinchick S, Knappertz V, Comi G. Long-term safety and tolerability of glatiramer acetate 20 mg/ml in the treatment of relapsing forms of multiple sclerosis. Expert Opinion on Drug Saftey 2017; 16 : 247-255.

MediathekInformation und Wissen
LageplanSo finden Sie uns